Home/Recalls/CANADA-51713
Health CanadaGeneral Alert

ARZERRA (ofatumumab) - Fatal Infusion Reaction Reported in a Patient with Chroni...

Published: August 6, 2014Recall ID: 51713Category: generalCountry: Canada

Reason for Recall / Hazard

Product safety

Product Description & Identification

ARZERRA (ofatumumab) - Fatal Infusion Reaction Reported in a Patient with Chronic Lymphocytic Leukemia - For the Public

Additional Source Details

FieldValue
N I D51713
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/arzerra-ofatumumab-fatal-infusion-reaction-reported-patient-chronic-lymphocytic
IssueProduct safety
Title ARZERRA (ofatumumab) - Fatal Infusion Reaction Reported in a Patient with Chronic Lymphocytic Leukemia - For the Public
Archived1
CategoryBiologic or vaccine
Last updated2014-08-06
OrganizationMarketed health products

Overview

  • Recalling FirmMarketed health products
Official Agency Alert